T2 Biosystms Executives

TTOODelisted Stock  USD 0.18  0.05  21.74%   
T2 Biosystms employs about 113 people. The company is managed by 8 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 14.13 employees per reported executive. Analysis of T2 Biosystms' management performance can provide insight into the firm performance.
BSc III  CEO
CEO President
Alec Barclay  President
Senior Vice President - Operations
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

T2 Biosystms Management Team Effectiveness

The company has return on total asset (ROA) of (0.9046) % which means that it has lost $0.9046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.2214) %, meaning that it created substantial loss on money invested by shareholders. T2 Biosystms' management efficiency ratios could be used to measure how well T2 Biosystms manages its routine affairs as well as how well it operates its assets and liabilities.

T2 Biosystms Workforce Comparison

T2 Biosystms is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 214,173. T2 Biosystms adds roughly 113 in number of employees claiming only tiny portion of equities under Health Care industry.

T2 Biosystms Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific T2 Biosystms insiders, such as employees or executives, is commonly permitted as long as it does not rely on T2 Biosystms' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, T2 Biosystms insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

T2 Biosystms Notable Stakeholders

A T2 Biosystms stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as T2 Biosystms often face trade-offs trying to please all of them. T2 Biosystms' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting T2 Biosystms' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
BSc IIICEO PresidentProfile
Alec BarclaySenior Vice President - OperationsProfile
Roger SmithSenior DevelopmentProfile
Aparna MDChief BoardProfile
Kelley MorganChief OfficerProfile
Michael EsqSr CounselProfile
Brett GiffinChief OfficerProfile
John CPAChief OfficerProfile

About T2 Biosystms Management Performance

The success or failure of an entity such as T2 Biosystms often depends on how effective the management is. T2 Biosystms management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of TTOO management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the TTOO management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. T2 Biosystems operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 182 people.

T2 Biosystms Workforce Analysis

Traditionally, organizations such as T2 Biosystms use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare T2 Biosystms within its industry.

T2 Biosystms Manpower Efficiency

Return on T2 Biosystms Manpower

Revenue Per Employee63.7K
Revenue Per Executive899.1K
Net Loss Per Employee443.2K
Net Loss Per Executive6.3M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Consideration for investing in TTOO Pink Sheet

If you are still planning to invest in T2 Biosystms check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystms' history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets